Idiopathic Peripheral Autonomic Neuropathy (IPAN) and Pure Autonomic Failure (PAF): A Patient Guide
At a Glance
IPAN and PAF are disorders of the autonomic nerves that can disrupt blood pressure, digestion, and bladder control. Management combines individualized fluids and salt, non-drug measures, medicines, coordinated specialist care, and monitoring for possible movement, sleep, or memory changes.
What This Guide Cannot Do: This guide provides educational information. It cannot establish a diagnosis of PAF, determine the cause of your autonomic symptoms, or replace individualized advice about fluids, salt, pressor drugs, bladder care, or emergency symptoms.
Living with Idiopathic Peripheral Autonomic Neuropathy (IPAN) or Pure Autonomic Failure (PAF) means navigating a world where your body’s “autopilot”—the autonomic nervous system—no longer functions predictably. For many, the road to this diagnosis is a long “odyssey,” often taking years of searching and evaluating more common conditions like diabetes or autoimmune diseases [1]. When a diagnosis is labeled “idiopathic,” it simply means that while the physical damage to your nerves is real and documented (even if a definitive structural marker is not always found), a secondary “trigger” hasn’t been identified. In the case of PAF, the condition is recognized as a specific clinical syndrome of isolated autonomic failure where the nerves themselves are the primary site of the problem [2][3]. Terminology and diagnostic criteria can vary by autonomic center, and the two terms overlap clinically in many ways.
At the heart of these conditions is a breakdown in how your nerves communicate with your organs. In PAF, this is often associated with the abnormal buildup of a protein called alpha-synuclein (though a skin biopsy finding is supportive, not universally definitive) and the gradual loss of the ability to release norepinephrine, the chemical messenger that tells your blood vessels to tighten when you stand [4][5]. This biological failure leads to a complex balancing act in your daily life. You may struggle with neurogenic orthostatic hypotension (nOH)—a sharp drop in blood pressure when upright—while simultaneously facing supine hypertension, where your blood pressure climbs too high when you lie flat. This “tug-of-war” with gravity requires a specialized approach to hydration, physical tools, and medication [6][7].
The impact of autonomic failure rarely stops at blood pressure; it is a multisystem experience that can disrupt your digestion and bladder control. Because the “autopilot” also manages how food moves through your stomach and how your bladder stores and releases urine, you may face challenges like bloating, constipation, or urinary retention [8][9]. Managing these symptoms requires a coordinated effort between different specialists to ensure that a treatment for one system doesn’t accidentally worsen another. This comprehensive care is essential for maintaining your comfort and protecting your long-term health [10][11].
Looking ahead, the journey with IPAN and PAF involves careful, proactive monitoring. For those with PAF, there is a recognized possibility of phenoconversion, where the condition may later involve other parts of the nervous system, such as those that control movement or memory [12]. While this possibility can be daunting—and it is not inevitable—it underscores the importance of a dedicated care team that monitors for changes in sleep, gait, or cognition. By staying informed and engaged with your specialists, you can adapt your management plan over time, focusing on maintaining your independence and quality of life as you navigate this rare and complex condition [13][14].
In this guide
6 chapters
Understanding IPAN and PAF
Learn how IPAN and Pure Autonomic Failure differ, why they cause dizziness and blood pressure drops, and which tests help confirm autonomic nerve dysfunction.
Recognizing Symptoms and Knowing When to Seek Help
Learn how idiopathic peripheral autonomic neuropathy can cause dizziness, blood pressure drops, digestive and bladder symptoms, and when urgent care is needed.
The Search for Answers: Diagnostic Testing and Evaluation
Learn how idiopathic peripheral autonomic neuropathy is evaluated with autonomic reflex testing, CASS scoring, amyloidosis tests, and skin biopsy results.
The Balancing Act: Managing Blood Pressure and Gravity
Learn how idiopathic peripheral autonomic neuropathy affects blood pressure, including standing dizziness, nighttime hypertension, fluids, medicines, and safety.
Managing Digestion and Bladder Complications
Learn how idiopathic peripheral autonomic neuropathy affects digestion and bladder function, including tests, treatments, medication risks, and warning signs.
The Long-Term Path: Monitoring, Risk, and Future Outlook
Learn how IPAN (idiopathic peripheral autonomic neuropathy) is monitored, including phenoconversion risk, blood pressure, bladder/kidney safety, and follow-up.
Common questions in this guide
How are IPAN and Pure Autonomic Failure different?
What symptoms can IPAN or PAF cause?
How are IPAN and PAF diagnosed?
How can blood pressure problems be managed with IPAN or PAF?
Can Pure Autonomic Failure later affect movement or memory?
What kind of specialists help manage IPAN and PAF?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How do my specific test results distinguish between a general 'idiopathic' neuropathy and Pure Autonomic Failure?
- 2.Which of my autonomic symptoms—cardiovascular, digestive, or urinary—should we prioritize for management first?
- 3.What is our strategy for monitoring any changes in my movement, sleep, or memory over time?
- 4.Does my current care team include all the necessary specialists, such as a neurologist with autonomic expertise?
- 5.Are there non-drug changes I can make today to help stabilize my blood pressure during the day?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement.
Alnasser Alsukhni R, Vichayanrat E, Koay S, et al.
European journal of neurology 2024; (31(3)):e16169 doi:10.1111/ene.16169.
PMID: 38085264 - 2
Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies.
González-Duarte A, Varma-Doyle A, Freeman R
Current opinion in neurology 2021; (34(5)):675-682 doi:10.1097/WCO.0000000000000985.
PMID: 34392300 - 3
Autonomic Peripheral Neuropathy.
Freeman R
Continuum (Minneapolis, Minn.) 2020; (26(1)):58-71 doi:10.1212/CON.0000000000000825.
PMID: 31996622 - 4
Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies.
Lamotte G, Holmes C, Sullivan P, et al.
Annals of clinical and translational neurology 2020; (7(12)):2450-2460 doi:10.1002/acn3.51243.
PMID: 33216462 - 5
Cutaneous phosphorylated-synuclein: an early diagnostic biomarker for pure autonomic failure.
Koay S, Provitera V, Caporaso G, et al.
Journal of neurology, neurosurgery, and psychiatry 2025; (96(5)):500-507 doi:10.1136/jnnp-2024-334615.
PMID: 39608812 - 6
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
Gibbons CH, Schmidt P, Biaggioni I, et al.
Journal of neurology 2017; (264(8)):1567-1582 doi:10.1007/s00415-016-8375-x.
PMID: 28050656 - 7
What do we really know about supine hypertension in patients with orthostatic hypotension.
Jordan J, Tank J, Heusser K, et al.
Current opinion in cardiology 2019; (34(4)):384-389 doi:10.1097/HCO.0000000000000633.
PMID: 31021876 - 8
Diabetic Gastroparesis: Principles and Current Trends in Management.
Krishnasamy S, Abell TL
Diabetes therapy : research, treatment and education of diabetes and related disorders 2018; (9(Suppl 1)):1-42 doi:10.1007/s13300-018-0454-9.
PMID: 29934758 - 9
The natural history of idiopathic autonomic failure: The IAF-BO cohort study.
Giannini G, Calandra-Buonaura G, Asioli GM, et al.
Neurology 2018; (91(13)):e1245-e1254 doi:10.1212/WNL.0000000000006243.
PMID: 30135257 - 10
Management of Orthostatic Hypotension: A Review.
Moloney D, Youssef A, Okamoto LE
JAMA internal medicine 2026; doi:10.1001/jamainternmed.2026.0284.
PMID: 41941194 - 11
Pure Autonomic Failure.
Thaisetthawatkul P
Current neurology and neuroscience reports 2016; (16(8)):74 doi:10.1007/s11910-016-0673-2.
PMID: 27338613 - 12
Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-Analysis.
Virameteekul S, Bonini I, Campese N, et al.
JAMA neurology 2026; (83(7)):616-624 doi:10.1001/jamaneurol.2026.0989.
PMID: 42081229 - 13
Pure autonomic failure: a natural history study of the Queen Square cohort.
Chiaro G, Vichayanrat E, Koay S, et al.
Brain : a journal of neurology 2026; (149(2)):606-619 doi:10.1093/brain/awaf191.
PMID: 40397689 - 14
Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
Clement G, Cavillon G, Vuillier F, et al.
Revue neurologique 2024; (180(1-2)):79-93 doi:10.1016/j.neurol.2023.12.004.
PMID: 38216420
This page provides educational information about IPAN and PAF; it is not medical advice and cannot diagnose your condition. Ask your clinicians about individualized fluids, salt, medications, bladder care, and emergency guidance.
Get notified when new evidence is published on idiopathic peripheral autonomic neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.